Journal
EPILEPSY & BEHAVIOR
Volume 65, Issue -, Pages 18-24Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.yebeh.2016.10.016
Keywords
Limbic encephalitis; GAD65 autoantibodies; Paraneoplastic autoantibodies; Immunotherapy; Epilepsy
Categories
Ask authors/readers for more resources
Objective: To determine the efficacy of immunotherapy in limbic encephalitis (LE) associated epilepsies with autoantibodies against intracellular antigens in the forms of paraneoplastic autoantibodies versus glutamic acid decarboxylase 65 (GAD)-autoantibodies. Methods: Eleven paraneoplastic-antibodies + and eleven age- and gender-matched GAD-antibodies + patients with LE were compared regarding EEG, seizure frequency, MRI volumetry of the brain, and cognition. All patients received immunotherapy with corticosteroids add-on to antiepileptic therapy. A few patients underwent additional interventions like immunoglobulins or immunoadsorption. Results: Immunotherapy led to a significantly greater proportion of seizure-free patients in the paraneoplastic antibodies + (55%) as compared to GAD-antibodies + (18%) patients (p < 0.05). Impaired cognition was evident initially (total cognitive performance score based on attentional-executive function, figural/verbal memory and word fluency) in 100% of the paraneoplastic-antibodies+ and 73% of the GAD-antibodies + group. After therapy, cognition improved significantly in the paraneoplastic-antibodies+, but not in the GAD-antibodies + patients (p < 0.05). Cognitive change did not correlate with the change in the number of antiepileptic drugs over time. MRI showed larger and unchanged volumes of the amygdala, presubiculum and subiculum in GAD antibodies + as compared to paraneoplastic-antibodies + patients (p < 0.05) over time. Conclusions: Our data provide evidence of a beneficial effect of immunotherapy added to antiepileptic drugs on seizure frequency and cognition only in the paraneoplastic-antibodies + subgroup of LE presenting autoantibodies against intracellular antigens. (C) 2016 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available